首頁 > 市場調查報告書 > 醫療設備

生技設備以基因為基之藥物開發

市場調查報告書

商品編碼

1623519

免標定檢測的全球市場規模:各技術，各類產品·服務，各終端用戶，各地區，範圍及預測

Global Label-Free Detection Market Size By Technology (Surface Plasmon Resonance, Bio-layer Interferometry), By Product & Service (Biosensor Chips, Microplates), By End User (Pharmaceutical & Biotechnology Companies), By Geographic Scope And Forecast

出版日期: 2024年07月20日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

無標記偵測的市場規模及預測

2023 年無標籤檢測市場規模價值 20.9 億美元，預計到 2030 年將達到 56.2 億美元，2024 年至 2030 年的複合年增長率為 14.1%。該市場的成長得益於先進技術產品的引進、透過產學研合作不斷增加的藥物研發項目以及無標記技術靈敏度的不斷提高。本研究報告對全球無標籤檢測市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義無標記偵測的全球市場

一種被稱為 "無標籤檢測系統" 的整合系統用於研究生物分子交互作用，而不會減少標籤或自發性螢光效應。這些技術為發現新藥提供了一種快速、即時的方法。採用無標籤檢測方法進行生化和基於細胞的測試。無標記檢測方法正被用於檢測生物分子及其相互作用。對於生物技術和製藥領域來說，這種方法是一種令人難以置信的研究和開發工具。由於製藥公司和學術機構之間的合作增加以及藥物研發計劃的增加，預計市場將蓬勃發展。

無標記檢測的全球市場概況

製藥和生物技術領域日益增多的研發活動正在推動全球無標籤檢測市場的發展。製藥活動的外包和學術機構研發活動的激增促使對無標記檢測技術的需求強勁。這些技術非常受歡迎，因為它們可以有效地管理多種訊號通路的複雜性。此外，無標記檢測技術消除了自發性螢光和空間幹擾的使用，從而促進了其應用。

政府和私人組織聯合舉辦研討會，以提高最終用戶對使用無標籤檢測技術的好處的認識，並有望確保市場的成長。除當前情況外，各企業不斷努力開發尖端無標記檢測技術也有望促進市場的成長。然而，無標記檢測所需設備的高成本預計會限制該市場的成長。此外，最終用戶缺乏專業知識以及對無標記檢測技術的各種優勢的認識較低也可能成為市場擴張的障礙。

Label-Free Detection Market size was valued at USD 2.09 Billion in 2023 and is projected to reach USD 5.62 Billion by 2030 , growing at a CAGR of 14.1% from 2024 to 2030. Growth during this market is driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and thus the high sensitivity of label-free technologies. The Global Label-Free Detection Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Label-Free Detection Market Definition

The type of integrated systems known as "label-free detection systems" are used to examine biomolecular interactions without lowering the labels or auto-fluorescent effects. These technologies provide a quick and real-time method for finding novel drugs. Biochemical and cell-based tests are detected by label-free detection methods. For the purpose of detecting biomolecules and their interactions, the label-free detection approach is used. This approach has become a wonderful research and development tool for the biotech and pharmaceutical sectors. The market will develop as a result of partnerships between pharmaceutical corporations and academic institutions and the rise in drug discovery programs.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Label-Free Detection Market Overview

The growing research and development activities within the field of pharmaceuticals and biotechnology are driving the worldwide Label-Free Detection Market. A surge in outsourcing pharmaceutical activities and R&D activities by academic institutions are together responsible for the high demand for label-free detection techniques. These techniques are in high demand as they effectively manage the complexity of multiple signaling pathways. Moreover, label-free detection techniques eliminate the utilization of autofluorescent and spatial interference, boosting their adoption.

Joint efforts by governments and private organizations to organize seminars and increase awareness among end-users regarding the benefits of using label-free detection techniques are expected to ensure the growth of the market. In addition to the current state, continued efforts by businesses to create cutting-edge label-free detection techniques will contribute to the market's growth. On the other hand, the high cost of the equipment required for label-free detection would limit this market's growth. The end-users lack of expertise and poor levels of awareness about the various advantages of label-free detection techniques would also be a barrier to the market's expansion.

Global Label-Free Detection Market Segmentation Analysis

The Global Label-Free Detection Market is Segmented on the basis of Technology, Product & Service, End User, And Geography.

Label-Free Detection Market, By Technology

Surface Plasmon Resonance
Bio-layer Interferometry
Differential Scanning Calorimetry
Isothermal Titration Calorimetry
Other Label-free Detection Technologies

Based on Technology, the market is bifurcated into Surface Plasmon Resonance, Bio-layer Interferometry, Differential Scanning Calorimetry, Isothermal Titration Calorimetry, And Other Label-free Detection Technologies. The biosensor chips accounted for the most important share of the consumables segment mainly owing to the high specificity and skill to watch molecular interactions in real-time.

Label-Free Detection Market, By Product & Service

Biosensor Chips
Microplates
Reagents & Kits

Based on Product & Service, the market is bifurcated into Biosensor Chips, Microplates, And Reagents & Kits. The surface plasmon resonance segment accounted for the foremost important share, attributable to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.

Label-Free Detection Market, By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (Cros)
Others

Based on End User, the market is bifurcated into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (Cros), And Others. The pharmaceutical & biotechnology companies segment dominated the Label-Free Detection Market, owing to the extensive use of label-free detection technologies by pharmaceutical & biotechnology companies for studying biomolecular interactions in drug discovery.

Label-Free Detection Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Regional Analysis, the Global Label-Free Detection Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America accounted for the most important share of the general market, followed by Europe. The availability of funds for research, increasing research activities in drug discovery and development, growth in pharmaceutical R&D spending, and the presence of key players are the major factors driving the North American market.

Key Players

The "Global Label-Free Detection Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
Medtronic, Koninklijke Philips N.V., Ambu, Cognionics, Inc., Natus Medical Incorporated, 3M, CONMED Corporation, Rhythmlink International, LLC, Leonhard Lang GmbH (Acquired By DCC PLC.), Nihon Kohden Corporation, Compumedics Limited, G.Tec Medical Engineering GmbH, SOMNOmedics GmbH, NeuroSky, General Healthcare (Subsidiary of General Electric Company).

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL LABEL-FREE DETECTION MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL LABEL-FREE DETECTION MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL LABEL-FREE DETECTION MARKET, BY TECHNOLOGY

5.1 Overview
5.2 Surface Plasmon Resonance
5.3 Bio-Layer Interferometry
5.4 Isothermal Titration Calorimetry
5.5 Differential Scanning Calorimetry
5.6 Other Lfd Technologies

6 GLOBAL LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE

6.1 Overview
6.2 Instruments
6.3 Consumables
- 6.3.1 Biosensor Chips
- 6.3.2 Microplates

7 GLOBAL LABEL-FREE DETECTION MARKET, BY END USER

7.1 Overview
7.2 Pharmaceutical & Biotechnology Companies
7.3 Academic & Research Institutes
7.4 Contract Research Organizations
7.5 Other End Users

8 GLOBAL LABEL-FREE DETECTION MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
8.6 Rest of the World

9 GLOBAL LABEL-FREE DETECTION MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 General Electric
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Danaher Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Perkinelmer
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Ametek
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 F. Hoffman-La Roche AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Malvern Panalytical
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 TA Instruments
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Corning Incorporated
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Horiba
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Shimadzu Corporation
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Hitachi High-Technologies Corporation
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments